GSK plc

Equities

GSK

GB00BN7SWP63

Market Closed - London S.E. Other stock markets 11:35:00 2026-01-12 am EST			5-day change	1st Jan Change
1,877.00 ^GBX	-0.48%		+3.10%	+2.88%

Jan. 12	Ionis Pharmaceuticals, Inc. Provides Additional Updates on Key Milestones Expected in 2026	CI
Jan. 12	Haisco Pharmaceutical Group Co., Ltd. Enters into an Exclusive Licensing Agreement with AirNexis	CI

Transcript : GSK plc Presents at Citi Annual Global Healthcare Conference 2025, Dec-04-2025

Published on 12/12/2025 at 11:50 am EST

S&P Capital IQ

Presenter Speech
Graham Glyn Parry (Analysts)

So we're ready now to start the next session. It's my pleasure to be able to introduce GSK. And from GSK, we have Deborah Waterhouse, who's the CEO of

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about GSK plc

Jan. 12	Ionis Pharmaceuticals, Inc. Provides Additional Updates on Key Milestones Expected in 2026	CI
Jan. 12	Haisco Pharmaceutical Group Co., Ltd. Enters into an Exclusive Licensing Agreement with AirNexis	CI
Jan. 12	Summit Therapeutics, GSK Team up on Clinical Trial for Combination Cancer Therapy	MT
Jan. 09	Healthcare dealmakers head to San Francisco hoping for megamergers in 2026	RE
Jan. 09	AnaptysBio Moves to Dismiss GSK's Tesaro Lawsuit Over Jemperli Royalty Dispute	MT
Jan. 09	Croda International Plc Announces Appointment of Jill Anderson as Non-Executive Director and Member of the Audit, Nomination and Remuneration Committees, Effective January 12, 2026	CI
Jan. 09	UK Stocks-Factors to watch on January 9	RE
Jan. 08	Johnson & Johnson Reaches Deal With Trump Administration to Lower Drug Prices	DJ
Jan. 08	AnaptysBio seeks partial dismissal in GSK oncology unit dispute over drug royalty	RE
Jan. 08	AnaptysBio Files to Dismiss Tesaro's Claim it Breached Royalties Contract	DJ
Jan. 08	Anaptys files motion to dismiss Tesaro's claim of anticipatory breach of contract in ongoing litigation	RE
Jan. 08	Praxis Precision Medicines, Inc. Announces Management Changes	CI
Jan. 08	GSK : Berenberg reaffirms its Neutral rating	ZD
Jan. 08	GSK : Deutsche Bank sticks Neutral	ZD
Jan. 07	GSK plc Appoints Luke Victor Miels as Director, Effective January 1, 2026	CI
Jan. 07	European Stocks Close Mixed in Wednesday Trading; Euro Area Inflation Declines in December	MT
Jan. 07	European Indices Diverge Following U.S. Employment Data
Jan. 07	Alert wrongly tagged to Helix Resources withdrawn	RE
Jan. 07	Helix announces multi-year strategic collaboration with GSK	RE
Jan. 07	GSK : JP Morgan reiterates its Sell rating	ZD
Jan. 07	Helix announces multi-year strategic collaboration with GSK to drive precision medicine development	RE
Jan. 07	GSK : Jefferies gives a Buy rating	ZD
Jan. 07	GSK plc Announces the European Commission's Approval of Shingrix in Prefilled Syringe	CI
Jan. 07	GSK plc Announces Positive Topline Results from B-Well 1 and B-Well 2 Phase 3 Studies for Bepirovirsen	CI
Jan. 07	GSK plc Announces Positive Results from Two Pivotal Phase 3 Studies, B-Well 1 and B-Well 2, Evaluating the Safety and Efficacy of bepirovirsen	CI